These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17628912)
1. Low-dose glucocorticoids in hyperandrogenism. Rizzo L; Dobrovsky V; Danilowicz K; Kral M; Cross G; Serra HA; Bruno OD Medicina (B Aires); 2007; 67(3):247-52. PubMed ID: 17628912 [TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884 [TBL] [Abstract][Full Text] [Related]
3. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens. Kamenicky P; Houdoin L; Ferlicot S; Salenave S; Brailly S; Droupy S; Meduri G; Sasano H; Suzuki T; Young J; Chanson P Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424 [TBL] [Abstract][Full Text] [Related]
4. [Effect of a betamethasone-dimethidine-maleate combination on dermatologic diseases. Determination of plasma cortisol levels before, during and after several days' therapy]. Venitz J; Lücker PW; Niehaus H Fortschr Med; 1984 Sep; 102(35):882-4. PubMed ID: 6489896 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone suppression test in the management of hyperandrogenized patients. Abraham GE; Maroulis GB; Boyers SP; Buster JE; Magyar DM; Elsner CW Obstet Gynecol; 1981 Feb; 57(2):158-65. PubMed ID: 6450905 [TBL] [Abstract][Full Text] [Related]
6. Managing cutaneous manifestations of hyperandrogenic disorders: the role of oral contraceptives. Wiegratz I; Kuhl H Treat Endocrinol; 2002; 1(6):372-86. PubMed ID: 15832490 [TBL] [Abstract][Full Text] [Related]
7. Biological variation of total testosterone, free androgen index and bioavailable testosterone in polycystic ovarian syndrome: implications for identifying hyperandrogenaemia. Cho LW; Kilpatrick ES; Jayagopal V; Diver MJ; Atkin SL Clin Endocrinol (Oxf); 2008 Mar; 68(3):390-4. PubMed ID: 17888022 [TBL] [Abstract][Full Text] [Related]
8. Treatment of female hyperandrogenism: estroprogestinic therapy at low dose in an inversal sequential scheme. Ragonesi FP; Lo Mastro F; Arena V; Ermini M Acta Eur Fertil; 1995; 26(4):141-3. PubMed ID: 9098476 [TBL] [Abstract][Full Text] [Related]
9. [Prolonged remission of female hyperandrogenism after discontinuing glucocorticoid therapy]. Devoto E; Aravena L; Gaete X Rev Med Chil; 1995 Feb; 123(2):207-14. PubMed ID: 7569461 [TBL] [Abstract][Full Text] [Related]
10. The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia. Mueller A; Cupisti S; Binder H; Hoffmann I; Beckmann MW; Dittrich R In Vivo; 2006; 20(3):403-7. PubMed ID: 16724679 [TBL] [Abstract][Full Text] [Related]
11. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747 [TBL] [Abstract][Full Text] [Related]
12. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency. Maguire AM; Ambler GR; Moore B; McLean M; Falleti MG; Cowell CT Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782 [TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation on glucocorticoid administration in the neurosurgical patients (the third report)--serial plasma cortisol assay following betamethasone 8 mg intravenous injection (author's transl)]. Yoshimoto H; Mori S; Matsumura S; Ohta M; Kajiwara S No Shinkei Geka; 1977 Nov; 5(12):1247-51. PubMed ID: 563529 [TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
15. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations. Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543 [TBL] [Abstract][Full Text] [Related]
16. [Effect on skin and hormonal hyperandrogenic manifestations of an oral estroprogestin association containing ethynilestradiol 30 mg and drospirenone 3 mg]. Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Pallotta P; Sorge R; Bilchugova E; Raskovic D Minerva Ginecol; 2008 Jun; 60(3):239-43. PubMed ID: 18547986 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of hyperandrogenism and hyperinsulinemia in PCOS patients with essential amino acids. A pilot clinical study]. Unfer V; Zacchè M; Serafini A; Redaelli A; Papaleo E Minerva Ginecol; 2008 Oct; 60(5):363-8. PubMed ID: 18854802 [TBL] [Abstract][Full Text] [Related]
18. Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Buoni S; Zannolli R; Sorrentino L; Fois A Arch Neurol; 2006 Oct; 63(10):1479-82. PubMed ID: 17030666 [TBL] [Abstract][Full Text] [Related]
20. Bioavailable testosterone should be used for the determination of androgen levels in infertile men. Ashok S; Sigman M J Urol; 2007 Apr; 177(4):1443-6; quiz 1591. PubMed ID: 17382750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]